Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
1.
Scand J Med Sci Sports ; 26(10): 1160-70, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26589249

ABSTRACT

Although the intake of nonsteroidal anti-inflammatory drugs (NSAIDs) intake by athletes prevents soreness, little is known concerning their role in exercise performance. This study assessed the effects of ibuprofen intake on an exhaustive protocol test after 6 weeks of swimming training in rats. Animals were divided into sedentary and training groups. After training, animals were subdivided into two subsets: saline or ibuprofen. Afterwards, three repeated swimming bouts were performed by the groups. Ibuprofen (15 mg/kg) was administered once a day. Pain measurements were performed and inflammatory and oxidative stress parameters were assayed in cerebral cortex and gastrocnemius muscle. Training, ibuprofen administration, or both combined (P < 0.05; 211 ± 18s, 200 ± 31s, and 279 ± 23s) increased exercise time to exhaustion. Training decreased the acetylcholinesterase (AChE) activity (P < 0.05; 149 ± 11) in cerebral cortex. Ibuprofen intake decreased the AChE activity after exhaustive protocol test in trained and sedentary rats (P < 0.05; 270 ± 60; 171 ± 38; and 273 ± 29). It also prevented neuronal tumor necrosis factor-α (TNF-α) and interleukin (IL 1ß) increase. Fatigue elicited by this exhaustive protocol may involve disturbances of the central nervous system. Additive anti-inflammatory effects of exercise and ibuprofen intake support the hypothesis that this combination may constitute a more effective approach. In addition, ergogenic aids may be a useful means to prevent exercise-induced fatigue.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Fatigue/prevention & control , Ibuprofen/pharmacology , Physical Conditioning, Animal/physiology , Physical Endurance/drug effects , Acetylcholinesterase/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cerebral Cortex/metabolism , Fatigue/metabolism , Ibuprofen/therapeutic use , Interleukin-1beta/metabolism , Male , Muscle, Skeletal/metabolism , Neurons/drug effects , Neurons/metabolism , Oxidative Stress/drug effects , Pain/etiology , Pain/prevention & control , Pain Measurement , Protein Carbonylation , Random Allocation , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Swimming/physiology , Tumor Necrosis Factor-alpha/metabolism
2.
Arch Pediatr ; 22(3): 303-5, 2015 Mar.
Article in French | MEDLINE | ID: mdl-25482996

ABSTRACT

Local anesthetic intoxication is an uncommon complication of regional anesthesia. We report the case of a 4-month-old infant who presented with generalized tonic-clonic seizure complicated by cardiac arrest secondary to a severe intoxication to local anesthesia. These complications were observed after a bilateral dorsal penile nerve block with lidocaine for circumcision in a non-hospital setting. This report emphasizes the potential risk of local anesthetic systemic toxicity in such circumstances and describes its treatment.


Subject(s)
Anesthesia, Local/adverse effects , Anesthetics, Local/poisoning , Circumcision, Male , Epilepsy, Tonic-Clonic/chemically induced , Heart Arrest/chemically induced , Lidocaine/poisoning , Nerve Block/adverse effects , Child, Preschool , Humans , Male , Severity of Illness Index
3.
Eur J Clin Microbiol Infect Dis ; 31(10): 2481-90, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22466969

ABSTRACT

The objective of this review was to summarize the current knowledge base on the prevention of nosocomial infections in pediatric intensive care units (PICUs). Healthcare-associated infections (HAIs) are a crucial problem in PICUs because of their impact on patient outcome, length of hospital stay, and costs. Studies published between 1998 and 2011 were identified using the MEDLINE and Cochrane databases. Randomized, cohort, case-control studies, and meta-analyses concerning global strategies of prevention, general organization of the wards, general recommendations on antibiotic management, and measures for the prevention of ventilator-associated pneumonia (VAP), bloodstream infections (BSIs), urinary tract infections (UTIs), and surgical site infections (SSIs) were incorporated. Limits of age from 1 month to 18 years were used. When recommendations could not be supported by the pediatric literature, adult studies were also reviewed. This review excludes the neonate population. Specific pediatric data are often lacking so as to establish specific evidence-based pediatric recommendations. This review underlines the absolute necessity of pediatric studies and to harmonize the definitions of HAIs.


Subject(s)
Cross Infection/prevention & control , Intensive Care Units, Pediatric/standards , Pneumonia, Ventilator-Associated/prevention & control , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Bacteria/pathogenicity , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Databases, Factual , Evidence-Based Practice/standards , Guidelines as Topic , Humans , Length of Stay , Pneumonia, Ventilator-Associated/drug therapy , Pneumonia, Ventilator-Associated/epidemiology , Pneumonia, Ventilator-Associated/microbiology , Surgical Wound Infection/drug therapy , Surgical Wound Infection/epidemiology , Surgical Wound Infection/microbiology , Surgical Wound Infection/prevention & control , Urinary Tract Infections/drug therapy , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/prevention & control
4.
Neurology ; 71(22): 1764-9, 2008 Nov 25.
Article in English | MEDLINE | ID: mdl-18843099

ABSTRACT

BACKGROUND: Native American myopathy (NAM) is an autosomal recessive congenital myopathy first reported in the Lumbee Indian people. Features of NAM include congenital weakness, cleft palate, ptosis, short stature, and susceptibility to malignant hyperthermia provoked by anesthesia. METHOD: We identified five individuals with NAM from the Lumbee population, and hypothesized that these affected individuals have disease alleles shared identical-by-descent inherited from common ancestry. To identify a NAM disease locus, homozygosity mapping methods were employed on a genomewide 10K single-nucleotide polymorphism (SNP) screen. To confirm regions of homozygosity identified in the SNP screen, microsatellite repeat markers were genotyped within those homozygous segments. RESULTS: The SNP data demonstrated five regions of shared homozygosity in individuals with NAM. The additional genotyping data narrowed the region to one common segment of homozygosity spanning D12S398 to rs3842936 mapping to 12q13.13-14.1. Notably, loss of heterozygosity estimates from the SNP data also detected this same 12q region in the affected individuals. CONCLUSION: This study reports the first gene mapping of Native American myopathy (NAM) using single-nucleotide polymorphism-based homozygosity mapping in only a few affected individuals from simplex families and identified a novel NAM locus. Identifying the genetic basis of NAM may suggest new genetic etiologies for other more common conditions such as congenital myopathy and malignant hyperthermia.


Subject(s)
Chromosomes, Human, Pair 12 , Indians, North American/genetics , Myopathies, Structural, Congenital/genetics , Adolescent , Adult , Consanguinity , Contracture/genetics , DNA Mutational Analysis , DNA Primers , Female , Genetic Predisposition to Disease , Haplotypes , Homozygote , Humans , Loss of Heterozygosity , Male , Malignant Hyperthermia/genetics , Muscle Weakness/genetics , Myopathies, Structural, Congenital/complications , North Carolina , Polymorphism, Single Nucleotide , Young Adult
5.
Arch Pediatr ; 11(7): 879-84, 2004 Jul.
Article in French | MEDLINE | ID: mdl-15234393

ABSTRACT

OBJECTIVES: The purpose was to identify clinical presentation leading to admission to PICU of children affected by influenza, to describe predisposing factors and outcome and to propose preventive measures. METHODS: Ten years (1989-1999) retrospective study carried out in the ten beds PICU. Every child in PICU with an influenza positive culture was enrolled. RESULTS: Twenty four cases collected, aged two weeks-15 years (m =43 months), 19 males. Acute respiratory failure (16/24 =67%) was the first manifestation: pneumonia (13), bronchiolitis (2), status asthmaticus (1). Eleven children had underlying diseases including five immunocompromized. Thirteen patients required mechanical ventilation (mean duration: 22 days), seven developed ARDS (4 immunocompromized) and three died. Central nervous system was the second system affected (8 cases). Four exhibited a chronical cerebral disease and five presented afebrile status epilepticus which required i.v. barbiturates and mechanical ventilation (mean duration: 22 hours). One presented encephalitis, one an apparent life-threatening event, both had a favorable outcome. One child exhibited severe hyperpyrexia and died from multiorgan failure. CONCLUSION: Severe forms of influenza are rare in children but may lead to life-threatening conditions and death(16.5%). Most occur in children with underlying disease, particularly immunocompromized who may exhibit ARDS.


Subject(s)
Influenza, Human/therapy , Intensive Care Units, Pediatric/statistics & numerical data , Adolescent , Asthma/complications , Child , Child, Preschool , Cross Infection , Female , Hospitalization , Humans , Immunocompromised Host , Infant , Infant, Newborn , Influenza Vaccines/therapeutic use , Influenza, Human/drug therapy , Influenza, Human/etiology , Male , Multiple Organ Failure/etiology , Pneumonia/complications , Prognosis , Respiration, Artificial , Respiratory Insufficiency/etiology , Retrospective Studies , Risk Factors , Status Epilepticus/complications , Treatment Outcome
6.
Arch Pediatr ; 10 Suppl 5: 539s-544s, 2003 Dec.
Article in French | MEDLINE | ID: mdl-15022778

ABSTRACT

OBJECTIVE: The objective of this study was to ascertain the clinical and epidemiological characteristics of Pneumocystis carinii pneumonia (PCP) cases admitted to the Pediatric Intensive Care Unit (PICU). PATIENTS AND METHODS: A retrospective study was carried out for the 10 PCP cases admitted to the PICU from 1980 to 2002. The variables studied were: age, sex, PRISM, underlying diseases, immunological status, clinical manifestations, radiology, response to therapy and clinical follow up. RESULTS: Age of the patients varied between 5 months and 15 years and 4 months and there were 7 females and 3 males. Underlying diseases included: AIDS (3 cases), renal transplant (2 cases), West syndrome (1 case), cancer (4 cases). All presented an acute respiratory failure and 8/10 needed mechanical ventilation (mean duration: 14 days). All were treated by trimethoprim-sulfamethoxazole and 6/10 received steroids. Only one child died. CONCLUSION: PCP is rare and affects mainly immunocompromised children who exhibit ARDS. Steroids treatment is now considered as an useful therapeutic adjuvant. A preventive treatment should be administered to children at risk.


Subject(s)
Pneumocystis carinii , Pneumonia, Pneumocystis , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Pneumonia, Pneumocystis/diagnosis , Pneumonia, Pneumocystis/therapy , Retrospective Studies
7.
Gut ; 49(4): 526-33, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11559650

ABSTRACT

BACKGROUND: Invasion of the intestinal mucosa by leucocytes is a characteristic of intestinal inflammation but the role of the epithelium in orchestrating this recruitment has not been examined in vivo. Cultured intestinal epithelial cells secrete a wide variety of chemokines, often in response to agents present in the intestinal lumen. Macrophage inflammatory protein 2 (MIP-2) is a chemokine that attracts neutrophils, and its secretion from intestinal epithelial cells is enhanced by inflammatory stimuli such as interleukin 1beta. We hypothesised that the production of MIP-2 by epithelial cells would increase leucocyte migration into the intestine. AIM: To study the effects of a chemokine secreted from intestinal epithelial cells in vivo. METHODS: MIP-2 was expressed in the mouse intestinal epithelium using an epithelial cell specific promoter from the gene encoding the intestinal fatty acid binding protein. The intestines of these transgenic mice were then analysed. RESULTS: Epithelial cells from transgenic mice expressed MIP-2 but wild-type mice did not. Neutrophil recruitment, examined by myeloperoxidase (MPO) staining and total MPO activity per unit weight of intestine, was significantly increased in transgenic mice in both the small intestine and proximal colon, and this was blocked by anti-MIP-2 antibody treatment. Both intraepithelial and lamina propria lymphocytes were also increased in transgenic mice. They showed chemotactic activity to MIP-2 in the Boyden chambers and expressed MIP-2 receptor (CXCR-2) mRNA confirmed by reverse transcription-polymerase chain reaction. CONCLUSION: These experiments are the first to show a functional role for epithelial chemokines in vivo and reveal an unexpected role for the neutrophil chemokine MIP-2 in controlling mucosal lymphocyte migration.


Subject(s)
Chemotaxis, Leukocyte/physiology , Intestinal Mucosa/metabolism , Lymphocytes/physiology , Monokines/metabolism , Neutrophil Infiltration/physiology , Animals , Chemokine CXCL2 , Chemokines, CXC , Epithelium/immunology , Epithelium/metabolism , Immunity, Cellular , Intercellular Signaling Peptides and Proteins , Mice , Mice, Transgenic , Peroxidase/metabolism , RNA, Messenger/analysis , Receptors, Chemokine/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Staining and Labeling/methods
8.
Paediatr Anaesth ; 11(1): 93-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11123739

ABSTRACT

We studied, retrospectively, postoperative infectious complications following paediatric liver transplantation at a single university centre. The objectives were to characterize the epidemiology of infection and to determine the associated risk factors during the early postoperative period, either the first postoperative month or the entire duration of paediatric intensive care unit (PICU) stay. Forty-eight liver transplants were performed on 46 patients. Sixty-three infections occurred in 32 patients who underwent 34 liver transplantations (1.36 infection/patient); 47 were bacterial, 6 fungal and 10 viral. The most common sites of infection were bloodstream (36.5%) and abdomen (30%). Gram-positive bacteria (78%) predominated over gram-negative bacteria (22%). Initial analysis revealed infection risk factors to be age <1 year, body weight <10 kg, extrahepatic biliary atresia, intraoperative transfusion > 160 ml x kg(-1), mechanical ventilation > 8 days and PICU stay > 19 days. After stratified analysis, the main risk factor for infection was low body weight of the recipient.


Subject(s)
Infections/etiology , Liver Transplantation/adverse effects , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infections/diagnosis , Infections/microbiology , Intensive Care Units, Pediatric , Male , Reoperation , Retrospective Studies , Risk Factors
9.
Pediatrics ; 106(2 Pt 1): 311-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10920157

ABSTRACT

UNLABELLED: Inhaled albuterol is the most frequently used bronchodilator for acute wheezing, and nebulization is the standard mode of delivery in hospital setting. However, recent guidelines consider spacer devices as an easier to use, and cost-saving alternative and recommend the high-dose metered-dose inhaler bronchodilator. OBJECTIVE: To demonstrate clinical equivalence between a spacer device and a nebulizer for albuterol administration. DESIGN: Randomized, double-blind, parallel group equivalence trial. SETTING: Pediatric emergency wards at 2 tertiary teaching hospitals. PATIENTS: Sixty-four 12- to 60-month-old children with acute recurrent wheezing (32 per group). INTERVENTIONS: Albuterol was administered through the spacer device (50 microg/kg) or through the nebulizer (150 microg/kg) and repeated 3 times at 20-minute intervals. Parents completed a questionnaire. OUTCOME MEASURES: Pulmonary index, hospitalization, ease of use, acceptability, and pulse oximetry saturation. RESULTS: The 90% confidence interval of the difference between treatment groups for the median absolute changes in pulmonary index values between T0 and T60 was [-1; +1] and was included in the equivalence interval [-1.5; +1.5]. Clinical improvement increased with time. Less than 10% of the children (3 in each group) required hospitalization (2 in each group attributable to treatment failure). Parents considered administration of albuterol using the spacer device easier (94%) and better accepted by their children (62%). CONCLUSIONS: The efficacy of albuterol administered using the spacer device was equivalent to that of the nebulizer. Given its high tolerance, repeated 50-microg/kg doses of albuterol administered through the spacer device should be considered in hospital emergency departments as first-line therapy for wheezing.


Subject(s)
Albuterol/administration & dosage , Bronchodilator Agents/administration & dosage , Nebulizers and Vaporizers , Respiratory Sounds/drug effects , Acute Disease , Albuterol/adverse effects , Bronchodilator Agents/adverse effects , Child, Preschool , Dose-Response Relationship, Drug , Double-Blind Method , Equipment Design , Female , Humans , Infant , Male , Recurrence , Therapeutic Equivalency
11.
Arch Pediatr ; 7 Suppl 3: 565s-571s, 2000 Jun.
Article in French | MEDLINE | ID: mdl-10941481

ABSTRACT

Bacterial meningitis in the newborn and infant remains a serious problem, with a mortality rate of 24% and a morbidity rate ranging from 30 to 50%. This retrospective study conducted between January 1982 and December 1997, aims to characterize the epidemiology of bacterial meningitis in infants less than 60 days of age. Thirty-five infants between 6 and 60 days of age, hospitalized for bacterial meningitis in the pediatric units of Edouard-Herriot Hospital in Lyon, France, were included. The clinical presentation was not specific for most cases, hyperthermia being the most common symptom (97%). Neurological symptoms such as bulging fontanelle or nuchal rigidity were present in 30% and 8% of the cases, respectively. The four predominant meningeal pathogens were: group B streptococcus (36%), Escherichia coli (28%), meningogoccus (8.6%) and Staphylococcus aureus (8.6%). This study emphasizes the importance of prompt diagnosis, including CSF evaluation, and antimicrobial therapy in infants less than 2 months of age presenting an isolated fever.


Subject(s)
Fever/etiology , Meningitis, Bacterial/epidemiology , Anti-Bacterial Agents/therapeutic use , Cerebrospinal Fluid/microbiology , Diagnosis, Differential , Female , Humans , Infant , Infant, Newborn , Male , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/pathology , Retrospective Studies
12.
Arch Pediatr ; 7(4): 369-76, 2000 Apr.
Article in French | MEDLINE | ID: mdl-10793923

ABSTRACT

BACKGROUND: Liver transplantation (LT) is the treatment of end-stage liver disease in children. We report our experience with LT using grafts from living related (LRD) and cadaver donors (CD). POPULATION: From March 1991 to March 1997, 40 children and infants received a total of 42 liver grafts. A reduced-size liver was used in 28 cases. We studied pre-transplantation status, survival rate, and medical and surgical complications in these patients. RESULTS: The survival rate in our series was respectively 85 and 80% at 1 and 7 years after LT. Low weight infants required a prolonged ventilatory assistance. Five of the six deaths noticed during the first three months after LT occurred in children weighing less than 12 kg. One year after LT, no significant difference in the incidence of rejection was found, neither between low-weight children and the others, nor between patients transplanted from CD or LRD. Biliary tract stricture was the major surgical complication. CONCLUSION: This series consisted of a majority of low-weight children. The survival rate in the patients weighting less than 12 kg is lower than in the others. This may be explained by the nutritional status of these patients and early postsurgical complications. The use of grafts from living donors offers more flexibility since the operation is performed electively, but it did not seem to modify the incidence of acute rejections and surgical complications.


Subject(s)
Graft Rejection , Liver Failure/therapy , Liver Transplantation , Adolescent , Body Weight , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Nutritional Status , Transplantation, Autologous , Treatment Outcome
17.
Arch Pediatr ; 3(8): 769-74, 1996 Aug.
Article in French | MEDLINE | ID: mdl-8998529

ABSTRACT

BACKGROUND: Several methods of dialysis are currently available. The choice of whether to use one of them is determined by multiple factors that are analyzed in this study. PATIENTS AND METHODS: One hundred and twenty-six children (mean age: 48 +/- 6 months) were treated in 29 French intensive care units and/or departments of nephrology during 1991. The underlying diseases were: hemolytic-uremic syndrome (HUS) in 28% of patients, other renal diseases in 6%, metabolic diseases in 8%, septic shock in 8%, cardiogenic shock in 9%, hypovolemic shock in 10%, multiple organ failure in 7%, acute liver disease in 9% and other diseases in 15%. RESULTS: Peritoneal dialysis (PD) was the favorite method in patients less than 10 years: intermittent hemodialysis (IHD), continuous hemofiltration and hemodiafiltration, (HF, HDF) were preferentially used above this age. PD was used in 85% of HUS, 58% of shocks and 50% of metabolic diseases. Sixty percent of acute renal diseases other than HUS were treated by IHD. HF and HDF were used in 66% of acute liver diseases and 42% of shocks. Overall mortality was 40% but no death could be directly ascribed to the different methods of dialysis. CONCLUSION: The choice of method depends on the type of underlying disease, age of the patient but also the equipment of centers. Progress in evaluating indications and results of the different methods of dialysis are necessary.


Subject(s)
Hemodiafiltration/statistics & numerical data , Hemofiltration/statistics & numerical data , Peritoneal Dialysis/statistics & numerical data , Renal Dialysis/statistics & numerical data , Adolescent , Adult , Age Factors , Child , Child, Preschool , Female , Health Surveys , Hemodiafiltration/methods , Hemofiltration/methods , Humans , Infant , Infant, Newborn , Male , Mortality , Peritoneal Dialysis/methods , Renal Dialysis/methods , Retrospective Studies
18.
Arch Pediatr ; 3(4): 342-4, 1996 Apr.
Article in French | MEDLINE | ID: mdl-8762955

ABSTRACT

BACKGROUND: The introduction of vaccines against Haemophilus influenzae type b (Hib) has had a substantial impact on Hib infections. Their use has established their excellent safety profiles but occasional adverse effects have been reported. CASE REPORT: A 4 month-old infant was admitted for a severe form of Hib meningitis with septicemia whose first manifestations developed 3 hours after the first immunization with a conjugate vaccine against Hib (PRP-T). The outcome was good without any sequelae. DISCUSSION: A dramatic decrease in serum antibodies due to antigen-antibody reaction during the first days after immunization has been reported; this mechanism and some epidemiological data could favor the hypothesis that the vaccine is responsible for the infection, at least the unconjugated vaccines. CONCLUSION: Any fever occurring in the immediate post-immunization period must alert the possibility of a Hib infection.


Subject(s)
Haemophilus Vaccines/adverse effects , Meningitis, Haemophilus/etiology , Antigen-Antibody Reactions , Female , Haemophilus Vaccines/immunology , Humans , Infant , Meningitis, Haemophilus/immunology
19.
Eur J Pediatr ; 154(8): 621-3, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7588960

ABSTRACT

UNLABELLED: In this study, 144 consecutive percutaneous liver biopsies performed with a 1.6 mm Menghini needle, during a 2-year period were reviewed. All the children were aged under 15 years, 57 patients less than 1 year and 87 more than 1 year. All biopsies were adequate and the mean number of portal tracts examined was 17.6 per biopsy (14.3 in patients weighing less than 10 kg and 19.1 in the others). There were no deaths and we observed only bleeding complications. In patients with normal coagulation (128 cases), 1 bleeding requiring transfusion occurred; and in patients with abnormal coagulation (16 cases), we observed 2 bleeding cases requiring transfusion. CONCLUSION: Percutaneous liver biopsy can be performed with 1.6 mm needles in children. For increased safety, ultrasound-guided biopsies are recommended.


Subject(s)
Biopsy, Needle/instrumentation , Hemorrhage/etiology , Liver Diseases/pathology , Liver/pathology , Adolescent , Child , Child, Preschool , Equipment Safety , Humans , Infant , Infant, Newborn , Liver Diseases/etiology
20.
Clin Otolaryngol Allied Sci ; 20(4): 336-9, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8548966

ABSTRACT

Between 1980 and 1993, 10 infants underwent endoscopic treatment and/or open surgical excision of a subglottic haemangioma. Of the eight children treated with the laser, four showed simple evolution following a single laser treatment, one required repeated laser treatments and two needed tracheotomy despite repeated laser treatments. The last three children developed moderate subglottic stenosis. Laser treatment was followed by open surgical excision in one child. Two children underwent primary surgical excision, allowing extubation between 8 and 10 days post-operatively. After a period in which we systematically treated subglottic haemangiomas with the laser, these findings have led us to employ open surgery in children with large subglottic haemangiomas or when airway obstruction requires a tracheostomy.


Subject(s)
Glottis/surgery , Hemangioma/surgery , Laryngeal Neoplasms/surgery , Airway Obstruction/physiopathology , Airway Obstruction/surgery , Female , Glottis/pathology , Hemangioma/pathology , Humans , Infant , Laryngeal Neoplasms/pathology , Laryngostenosis/surgery , Laser Therapy , Male , Trachea/physiopathology , Trachea/surgery , Tracheostomy
SELECTION OF CITATIONS
SEARCH DETAIL
...